What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Advances in the Management of RefractoryGastro hep advances · 2026
   Review
2. Antimicrobial Resistance Patterns and Determinants ofAntibiotics (Basel, Switzerland) · 2025
   Article
3. Diagnosis and treatment ofFuture microbiology · 2025
   Review
4. Antibiotic stress affects the secretion and physicochemical features of extracellular vesicles produced by Helicobacter pylori.The Journal of antimicrobial chemotherapy · 2025
   Article
5. Gastroenterology & hepatology · 2024
   Article
6. Change in Diagnosis ofAntibiotics (Basel, Switzerland) · 2024
   Review
7. Nrf2 Downregulation Contributes to Epithelial-to-Mesenchymal Transition inCancers · 2022
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as